Tannock I, Gordon Steel G
Br J Cancer. 2022; 128(3):413-418.
PMID: 36564562
PMC: 9938243.
DOI: 10.1038/s41416-022-02109-6.
Liu Y, Sun J, Wu T, Lu X, Du Y, Duan H
Cancer Med. 2019; 8(18):7603-7612.
PMID: 31663690
PMC: 6912063.
DOI: 10.1002/cam4.2654.
Nobre A, Entenberg D, Wang Y, Condeelis J, Aguirre-Ghiso J
Trends Cell Biol. 2018; 28(11):941-956.
PMID: 30041830
PMC: 6214449.
DOI: 10.1016/j.tcb.2018.06.008.
Kim T, Cavnar M, Cohen N, Sorenson E, Greer J, Seifert A
Clin Cancer Res. 2014; 20(9):2350-62.
PMID: 24583793
PMC: 4008656.
DOI: 10.1158/1078-0432.CCR-13-3033.
Hsieh C, Shyu W, Chiang C, Kuo J, Shen W, Liu R
PLoS One. 2011; 6(9):e23945.
PMID: 21935366
PMC: 3174133.
DOI: 10.1371/journal.pone.0023945.
Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia.
Carlson D, Keall P, Loo Jr B, Chen Z, Brown J
Int J Radiat Oncol Biol Phys. 2010; 79(4):1188-95.
PMID: 21183291
PMC: 3053128.
DOI: 10.1016/j.ijrobp.2010.10.007.
Modulation of the tumor suppressor protein alpha-catenin by ischemic microenvironment.
Plumb C, Adamcic U, Shahrzad S, Minhas K, Adham S, Coomber B
Am J Pathol. 2009; 175(4):1662-74.
PMID: 19745064
PMC: 2751562.
DOI: 10.2353/ajpath.2009.090007.
Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity.
Bennewith K, Durand R
Br J Cancer. 2001; 85(10):1577-84.
PMID: 11720448
PMC: 2363939.
DOI: 10.1054/bjoc.2001.2123.
Heterogeneous vascular dependence of tumor cell populations.
Yu J, Rak J, Carmeliet P, Nagy A, Kerbel R, Coomber B
Am J Pathol. 2001; 158(4):1325-34.
PMID: 11290550
PMC: 1891903.
DOI: 10.1016/S0002-9440(10)64083-7.
Proportion of infiltrating IgG-binding immune cells predict for tumour hypoxia.
Collingridge D, Hill S, Chaplin D
Br J Cancer. 2001; 84(5):626-30.
PMID: 11237382
PMC: 2363803.
DOI: 10.1054/bjoc.2000.1650.
Radioprotection by DNA ligands.
Martin R, Broadhurst S, DAbrew S, Budd R, Sephton R, Reum M
Br J Cancer Suppl. 1996; 27:S99-101.
PMID: 8763857
PMC: 2149991.
Regulation of intracellular pH in subpopulations of cells derived from spheroids and solid tumours.
Boyer M, Barnard M, Hedley D, Tannock I
Br J Cancer. 1993; 68(5):890-7.
PMID: 8217605
PMC: 1968730.
DOI: 10.1038/bjc.1993.451.
Cellular levels of photosensitisers in tumours: the role of proximity to the blood supply.
Korbelik M, Krosl G
Br J Cancer. 1994; 70(4):604-10.
PMID: 7917904
PMC: 2033422.
DOI: 10.1038/bjc.1994.358.
Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. II. RSU 1069.
Olive P
Br J Cancer. 1995; 71(3):537-42.
PMID: 7880736
PMC: 2033631.
DOI: 10.1038/bjc.1995.106.
Pharmacokinetics, binding and distribution of Hoechst 33342 in spheroids and murine tumours.
Olive P, Chaplin D, Durand R
Br J Cancer. 1985; 52(5):739-46.
PMID: 4063148
PMC: 1977212.
DOI: 10.1038/bjc.1985.252.
Pharmacokinetics in experimental and clinical chemotherapy.
Workman P
Cancer Chemother Pharmacol. 1986; 16(2):198-9.
PMID: 3948306
DOI: 10.1007/BF00256177.
Toxicity of 5-fluorouracil for aerobic and hypoxic cells in two murine tumours.
Tannock I
Cancer Chemother Pharmacol. 1987; 19(1):53-6.
PMID: 3815727
DOI: 10.1007/BF00296256.
Characterization of radiation resistant hypoxic cell subpopulations in KHT sarcomas. (I). Centrifugal elutriation.
Siemann D, Keng P
Br J Cancer. 1987; 55(1):33-6.
PMID: 3814473
PMC: 2001572.
DOI: 10.1038/bjc.1987.7.
Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
Durand R, Chaplin D
Br J Cancer. 1987; 56(2):103-9.
PMID: 3663461
PMC: 2002149.
DOI: 10.1038/bjc.1987.165.
The effects of melphalan and misonidazole on the vasculature of a murine sarcoma.
Murray J, Randhawa V, Denekamp J
Br J Cancer. 1987; 55(3):233-8.
PMID: 3552014
PMC: 2001746.
DOI: 10.1038/bjc.1987.45.
